226 filings
8-K
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
8-K
RGEN
Repligen Corp.
21 Feb 24
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
7:47am
8-K
RGEN
Repligen Corp.
15 Dec 23
Entry into a Material Definitive Agreement
4:33pm
8-K
RGEN
Repligen Corp.
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
8-K
RGEN
Repligen Corp.
31 Oct 23
Repligen Reports Third Quarter 2023 Financial Results
7:48am
8-K
657a87v
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
8-K
7dzd d061hxvflj1x
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
ymcu6
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
5ef53
2 Aug 23
Repligen Reports Second Quarter 2023 Financial Results
7:54am
8-K
d21qxmap
22 May 23
Amendments to Articles of Incorporation or Bylaws
9:28am
8-K
ipz ma4pef7dlprrc5yy
2 May 23
Repligen Reports First Quarter 2023 Financial Results
7:48am
8-K
d362kcj7 zzb
18 Apr 23
Other Events
7:26am
8-K
0g8sq74d
12 Apr 23
Regulation FD Disclosure
7:31am
8-K
srwa0pis
22 Feb 23
Repligen Reports Fourth Quarter and Full Year 2022 Financial Results
7:55am
8-K
5iu tlszjz8ilfm
9 Feb 23
Repligen Appoints Martin D. Madaus to Board of Directors
7:42am
8-K
xac3nnc9
1 Nov 22
Repligen Reports Third Quarter 2022 Financial Results
7:54am
8-K
0w8c alfz
2 Aug 22
Repligen Reports Second Quarter 2022 Financial Results
8:11am
8-K
ib0lu 4nmf9se63cse
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
8-K
oa8i rze4vgc
27 Apr 22
Repligen Reports First Quarter 2022 Financial Results
7:47am
8-K
401mb
8 Mar 22
Entry into a Material Definitive Agreement
7:43am